Michael K. Conway

Immunosciences Lab (United States)

Papers

2

Total Citations

28

H-Index

2

About

Michael K. Conway is a leading figure in the scalable manufacturing of induced pluripotent stem cells (iPSCs), a field critical to advancing regenerative medicine and drug discovery. His most cited work, "Scalable 96-well Plate Based iPSC Culture and Production Using a Robotic Liquid Handling System" (2015), with 22 citations, addresses a key bottleneck in stem cell research: transitioning from labor-intensive, small-scale cultures to high-throughput, automated production. Conway’s major contribution lies in demonstrating that robotic liquid handling systems can reliably maintain iPSC pluripotency and viability in a 96-well format, dramatically reducing costs and variability. This innovation directly supports the large-scale production of cells needed for tissue engineering, transplantation, and biopharmaceutical testing. By integrating automation with stem cell biology, Conway has helped bridge the gap between laboratory discovery and clinical application. His work is foundational for researchers aiming to produce consistent, high-quality iPSC-derived products, making him a pivotal contributor to the future of personalized and regenerative medicine.

Research Focus

Key Achievements

2
H-Index
2
Papers
28
Total Citations
14
Avg Citations/Paper
🏆 Most Cited Paper
Scalable 96-well Plate Based iPSC Culture and Production Using a Robotic Liquid Handling System
22 citations · 2015
📈 Most Prolific Year: 2015 (2 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Immunosciences Lab (United States)

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 16 days ago